Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.
Heliyon. 2024 Jan 17;10(2):e24550. doi: 10.1016/j.heliyon.2024.e24550. eCollection 2024 Jan 30.
Heliyon. 2024.
PMID: 38312697
Free PMC article.
Review.
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation.
Leelasukseree R, Chouyratchakarn W, Phutiyothin C, Pikwong F, Srisopar O, Baipaywad P, Udomsom S, Mongkolpathumrat P, Supanchart C, Kumphune S.
Leelasukseree R, et al. Among authors: phutiyothin c.
Sci Rep. 2023 Dec 27;13(1):23013. doi: 10.1038/s41598-023-50565-8.
Sci Rep. 2023.
PMID: 38155270
Free PMC article.
Item in Clipboard
Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury.
Pikwong F, Phutiyothin C, Chouyratchakarn W, Baipaywad P, Mongkolpathumrat P, Kumphune S.
Pikwong F, et al. Among authors: phutiyothin c.
Heliyon. 2023 Sep 16;9(9):e20150. doi: 10.1016/j.heliyon.2023.e20150. eCollection 2023 Sep.
Heliyon. 2023.
PMID: 37809945
Free PMC article.
Item in Clipboard
Cite
Cite